(Q36731127)

15 August 2017

1 reference

title

Thrombolytic therapy in cerebrovascular disorders (English)

1 reference

Cardiology and cardiovascular medicine

15 August 2017

1 reference

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

10 November 2022

author name string

S. R. Levine

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728786

10 November 2022

T. G. Brott

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1728786

10 November 2022

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=1728786

10 November 2022

publication date

1 January 1992

1 reference

full work available at URL

15 August 2017

https://api.elsevier.com/content/article/PII:003306209290020Z?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

https://api.elsevier.com/content/article/PII:003306209290020Z?httpAccept=text/plain

10 November 2022

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Progress in Cardiovascular Diseases

10 November 2022

published in

1 reference

15 August 2017

volume

34

1 reference

15 August 2017

issue

4

1 reference

15 August 2017

page(s)

235-262

1 reference

Cerebral angiography in acute cerebral infarction

15 August 2017

cites work

4

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombosis and cerebrovascular disease

10 November 2022

5

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Clinical and instrumental evaluation of patients with ischemic stroke within the first six hours.

10 November 2022

6

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Identification and entry of the patient with acute cerebral infarction

10 November 2022

7

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Early treatment for acute ischemic stroke

10 November 2022

8

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Brain tolerance to middle cerebral artery occlusion during hypotension in primates

10 November 2022

9

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Selective vulnerability of the brain: new insights into the pathophysiology of stroke

10 November 2022

10

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Temporary Occlusion of the Middle Cerebral Artery in the Monkey: Clinical and Pathological Observations

10 November 2022

11

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Sequential metabolic changes in rat brain following middle cerebral artery occlusion: a 2-deoxyglucose study

10 November 2022

12

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thresholds in cerebral ischemia - the ischemic penumbra

10 November 2022

13

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Viewing stroke pathophysiology: an analysis of contemporary methods

10 November 2022

14

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The Thrombolysis in Myocardial Infarction (TIMI) trial. Phase I findings.

10 November 2022

16

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Middle cerebral artery occlusion: correlation of computed tomography and angiography with clinical outcome

10 November 2022

17

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Occlusion of the middle cerebral artery; an experimental study

10 November 2022

18

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolysis and stroke. Past and future

10 November 2022

19

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Tissue plasminogen activator

10 November 2022

20

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Biochemical and clinical aspects of thrombolysis

10 November 2022

22

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolytic therapy: current status (2).

10 November 2022

23

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolytic therapy: current status (2).

10 November 2022

24

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Platelets and thrombolytic therapy

10 November 2022

25

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Biochemical pharmacology and therapeutic aspects of thrombolytic agents

10 November 2022

26

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

ANTICOAGULANTS PLUS STREPTOKINASE THERAPY IN PROGRESSIVE STROKE

10 November 2022

29

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

10 November 2022

Therapeutic thrombolysis

31

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The treatment of cerebrovascular thromboses and embolism with fibrinolytic agents

10 November 2022

33

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Early experience with fibrinolysin

10 November 2022

34

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The use of plasmin in humans

10 November 2022

35

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The use of plasmin in the treatment of intravascular thromboses

10 November 2022

36

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

A pilot study of urokinase therapy in cerebral infarction

10 November 2022

37

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

THERAPEUTIC THROMBOLYSIS IN CEREBRAL THROMBOEMBOLISM. DOUBLE-BLIND EVALUATION OF INTRAVENOUS PLASMIN THERAPY IN CAROTID AND MIDDLE CEREBRAL ARTERIAL OCCLUSION

10 November 2022

38

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolysis with fibrinolysin in cerebral arterial occlusion.

10 November 2022

41

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolysis with fibrinolysis in cerebral arterial occlusion; the role of angiography

10 November 2022

42

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Treatment of cerebrovascular thrombosis with fibrinolysin preliminary report∗

10 November 2022

44

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Fibrinolysin therapy in thrombotic diseases of the nervous system

10 November 2022

45

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Streptokinase, cerebral vascular disease - and triplets

10 November 2022

46

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

LYSIS OF INTRACEREBRAL THROMBOEMBOLISM WITH FIBRINOLYSIN. REPORT OF A CASE

10 November 2022

47

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Non-penetrating trauma to the carotid artery with secondary thrombosis and embolism: treatment by thrombolysin

10 November 2022

48

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Blood coagulation and plasma fibrinolytic enzyme system pathophysiology in stroke

10 November 2022

50

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Hemostatic markers in acute stroke

10 November 2022

51

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Resuscitation of the monkey brain after 1 h complete ischemia. I. Physiological and morphological observations.

10 November 2022

54

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease

10 November 2022

56

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Local intraarterial fibrinolytic therapy in inaccessible internal carotid occlusion

10 November 2022

57

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Vascular recanalizing techniques in interventional neuroradiology

10 November 2022

58

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Local intraarterial thrombolysis in vertebrobasilar thromboembolic disease

10 November 2022

59

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Local intraarterial fibrinolysis in acute vertebrobasilar occlusion. Technical developments and recent results

10 November 2022

60

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The beneficial effect of intracarotid urokinase on acute stroke in a baboon model

10 November 2022

62

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolytic therapy in cerebrovascular disease

10 November 2022

63

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolytic therapy in stroke: possibilities and hazards.

10 November 2022

64

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Local intra-arterial fibrinolytic therapy in acute carotid territory stroke. A pilot study.

10 November 2022

65

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Evoked potential monitoring during acute occlusion of the basilar artery and selective local thrombolytic therapy

10 November 2022

66

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Controlled trial of combined urokinase and dextran sulfate therapy in patients with acute cerebral infarction

10 November 2022

68

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Intra-arterial thrombolytic therapy improves outcome in patients with acute vertebrobasilar occlusive disease

10 November 2022

69

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Retrospective study on the efficacy of using urokinase therapy

10 November 2022

70

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Controlled Trial of Ancrod in Ischemic Stroke

10 November 2022

71

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Intracarotid urokinase with thromboembolic occlusion of the middle cerebral artery

10 November 2022

72

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Clinical effects and basic studies of thrombolytic therapy on cerebral thrombosis.

10 November 2022

73

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Ancrod causes rapid thrombolysis in patients with acute stroke

10 November 2022

76

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Hemorrhagic infarct of the brain without a reopening of the occluded arteries in cardioembolic stroke.

10 November 2022

77

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Lysis of basilar artery occlusion with tissue plasminogen activator

10 November 2022

81

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Tissue plasminogen activator thrombolysis of a middle cerebral artery embolus in a patient with an arteriovenous malformation. Case report

10 November 2022

82

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolytic therapy for thromboembolism of vertebrobasilar artery.

10 November 2022

88

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Intracranial thrombolysis via a catheter embedded in the clot

10 November 2022

89

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Thrombolytic therapy and posterior circulation extracranial-intracranial bypass for acute basilar artery thrombosis. Case report

10 November 2022

90

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Recombinant tissue plasminogen activator in two patients with basilar artery occlusion

10 November 2022

91

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Local recombinant tissue plasminogen activator to clear cerebral artery thrombosis developing soon after surgery

10 November 2022

92

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Vascular recanalizing techniques in the hind brain circulation.

10 November 2022

93

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Acceleration of thrombolysis with a high-dose transthrombus bolus technique.

10 November 2022

95

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

CEREBRAL EMBOLISM. ANGIOGRAPHIC OBSERVATIONS ON SPONTANEOUS CLOT LYSIS

10 November 2022

98

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Angiographic manifestations in postrecanalized cerebral infarction

10 November 2022

99

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Timing of autopsy-confirmed hemorrhagic infarction with reference to cardioembolic stroke

10 November 2022

100

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Special Problems Associated With Surgical and Thrombolytic Treatment of Strokes

10 November 2022

101

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Intracranial bleeding associated with urokinase therapy for acute ischemic hemispheral stroke

10 November 2022

102

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Intracranial hemorrhage after use of tissue plasminogen activator for coronary thrombolysis

10 November 2022

106

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Update from the Thrombolysis in Myocardial Infarction Trial

10 November 2022

108

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Stroke in patients treated with thrombolytic therapy for acute myocardial infarction. The thrombosis in myocardial infarction clinical trial and a review of placebo-controlled trials

10 November 2022

110

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Hemorrhagic complications associated with the use of intravenous tissue plasminogen activator in treatment of acute myocardial infarction

10 November 2022

111

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Intracerebral hemorrhage complicating intravenous tissue plasminogen activator treatment

10 November 2022

112

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Trial of tissue plasminogen activator for mortality reduction in acute myocardial infarction. Anglo-Scandinavian Study of Early Thrombolysis (ASSET).

10 November 2022

115

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Intracerebral hemorrhage related to cerebral amyloid angiopathy and t-PA treatment

10 November 2022

116

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Ruptured arteriovenous malformation complicating thrombolytic therapy with tissue plasminogen activator

10 November 2022

118

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Anticoagulant and thrombolytic therapy for cerebral embolism of cardiac origin

10 November 2022

120

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Errors and pitfalls in intraarterial thrombolytic therapy

10 November 2022

121

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Stroke complicating thrombolytic therapy of acute myocardial infarction

10 November 2022

124

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Hemorrhagic complications of thrombolytic therapy in the treatment of myocardial infarction and venous thromboembolism

10 November 2022

127

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

A randomized trial of immediate versus delayed elective angioplasty after intravenous tissue plasminogen activator in acute myocardial infarction

10 November 2022

129

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Morphological Responses of Cerebral Tissues to Temporary Ischemia

10 November 2022

133

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Early and late mechanisms of increased vascular permeability following experimental cerebral infarction

10 November 2022

134

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Racial differences in responses to thrombolytic therapy with recombinant tissue-type plasminogen activator. Increased fibrin(ogen)olysis in blacks. The Thrombolysis and Angioplasty in Myocardial Infarction Study Group.

10 November 2022

135

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Bleeding during thrombolytic therapy for acute myocardial infarction: mechanisms and management

10 November 2022

138

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Tissue plasminogen activator. Reduction of neurologic damage after experimental embolic stroke

10 November 2022

139

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Incidence of cerebral hemorrhage after treatment with tissue plasminogen activator or streptokinase following embolic stroke in rabbits [corrected]

10 November 2022

140

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Tissue plasminogen activator-mediated thrombolysis of cerebral emboli and its effect on hemorrhagic infarction in rabbits

10 November 2022

141

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Effect of intra-arterial tissue plasminogen activator and urokinase on autologous arterial emboli in the cerebral circulation of rabbits [corrected].

10 November 2022

142

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Stroke and acute Myocardial Infarction in the Thrombolytic era: Clinical correlates and long-term prognosis

10 November 2022

143

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Successful treatment of prosthetic heart-valve thrombosis with high short-term doses of streptokinase

10 November 2022

144

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Treatment of prosthetic tricuspid valve thrombosis with recombinant tissue-type plasminogen activator

10 November 2022

145

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Fibrinolytic treatment of thrombus on prosthetic heart valves

10 November 2022

146

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Plasminogen activator and cerebral infarction

10 November 2022

147

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Multiple microemboli after disintegration of clot during thrombolysis for acute myocardial infarction

10 November 2022

148

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Fatal ischaemic brain oedema after early thrombolysis with tissue plasminogen activator in acute stroke

10 November 2022

149

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Streptokinase clot lysis in acute occlusions of the cranial circulation: study in rabbits

10 November 2022

151

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Hemorrhagic complications of thrombolytic therapy in experimental stroke

10 November 2022

155

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Experimental thromboembolic stroke studied by positron emission tomography: immediate versus delayed reperfusion by fibrinolysis.

10 November 2022

156

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Streptokinase treatment versus calcium overload blockade in experimental thromboembolic stroke.

10 November 2022

158

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Tissue plasminogen activator reduces neurological damage after cerebral embolism.

10 November 2022

159

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The effect of intravenous tissue-type plasminogen activator in a rat model of embolic cerebral ischemia

10 November 2022

162

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Digital angiographic quantification of blood flow dynamics in embolic stroke treated with tissue-type plasminogen activator

10 November 2022

163

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Recombinant human tissue-type plasminogen activator therapy in acute thromboembolic stroke

10 November 2022

165

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Evaluation of recombinant tissue plasminogen activator in embolic stroke

10 November 2022

166

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The safety and angiographic efficacy of tissue plasminogen activator in a cerebral embolization model

10 November 2022

167

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Tissue plasminogen activator reduces brain injury in a rabbit model of thromboembolic stroke.

10 November 2022

169

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Differential sensitivity of erythrocyte-rich and platelet-rich arterial thrombi to lysis with recombinant tissue-type plasminogen activator. A possible explanation for resistance to coronary thrombolysis.

10 November 2022

171

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Hemorrhagic transformation following tissue plasminogen activator in experimental cerebral infarction

10 November 2022

172

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Recombinant plasminogen activator inhibitor-1 reverses the bleeding tendency associated with the combined administration of tissue-type plasminogen activator and aspirin in rabbits

10 November 2022

173

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The effects of a new tissue plasminogen activator analogue, Fb-Fb-CF, on cerebral reperfusion in a rabbit embolic stroke model

10 November 2022

175

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Delayed treatment with a t-PA analogue and streptokinase in a rabbit embolic stroke model.

10 November 2022

176

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Enhancement of thrombolysis with tissue-type plasminogen activator by pretreatment with heparin

10 November 2022

178

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Central retinal vein thrombosis: serial treatment with defibrination, aspirin and plasminotropic drugs

10 November 2022

182

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Fibrinolysin therapy in thrombotic diseases of the nervous system

10 November 2022

183

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Treatment of cerebrovascular thrombosis with fibrinolysin preliminary report∗

10 November 2022

184

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Treatment of central retinal vein thrombosis with ancrod

10 November 2022

185

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Clinical-Radiological Correlation in Cerebral Venous Occlusive Disease

10 November 2022

186

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Letter: Streptokinase therapy and cavernous sinus thrombosis

10 November 2022

187

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Streptokinase in central retinal vein occlusion: a controlled clinical trial

10 November 2022

188

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Superior Sagittal Sinus Thrombosis

10 November 2022

189

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Heparin-urokinase treatment in aseptic dural sinus thrombosis

10 November 2022

191

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Treatment of dural sinus thrombosis with local urokinase infusion. Case report

10 November 2022

193

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Lysis of intracranial hematomas with urokinase in a rabbit model.

10 November 2022

198

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Efficacy and safety of tissue plasminogen activator

10 November 2022

200

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

CT-guided stereotaxic evacuation of hypertensive intracerebral hematomas.

10 November 2022

201

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

CT-guided stereotactic fibrinolysis of spontaneous and hypertensive cerebellar hemorrhage: long-term results.

10 November 2022

202

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Safety and efficacy of intrathecal thrombolytic therapy in a primate model of cerebral vasospasm.

10 November 2022

203

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Intrathecal fibrinolytic therapy after subarachnoid hemorrhage: dosage study in a primate model and review of the literature.

10 November 2022

205

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Fibrinolysis in the central nervous system

10 November 2022

206

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

[Intrathecal irrigation with urokinase in ruptured cerebral aneurysm cases. Basic study and clinical application]

10 November 2022

209

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Modification of experimental post-subarachnoid hemorrhage vasculopathy with intracisternal plasmin

10 November 2022

211

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Modification of experimental post-subarachnoid hemorrhage vasculopathy with intracisternal plasmin

10 November 2022

212

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Effect of intrathecal thrombolytic therapy on subarachnoid clot and chronic vasospasm in a primate model of SAH

10 November 2022

214

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Injection of tissue plasminogen activator to prevent delayed vasospasm

10 November 2022

218

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Lysis of intraventricular blood clot with urokinase in a canine model: Part 1. Canine intraventricular blood cast model

10 November 2022

219

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Lysis of intraventricular blood clot with urokinase in a canine model: Part 2. In vivo safety study of intraventricular urokinase

10 November 2022

220

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Lysis of intraventricular blood clot with urokinase in a canine model: Part 3. Effects of intraventricular urokinase on clot lysis and posthemorrhagic hydrocephalus

10 November 2022

221

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Treatment of severe intraventricular hemorrhage by intraventricular infusion of urokinase

10 November 2022

222

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Lysis of intraventricular hematoma with tissue plasminogen activator. Case report

10 November 2022

223

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The investigational use of tPA for stroke

10 November 2022

225

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Neurological deficit and cerebral infarction after temporary middle cerebral artery occlusion in unanesthetized cats

10 November 2022

227

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

The effect of spontaneous reperfusion on metabolic function in early human cerebral infarcts

10 November 2022

228

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Investigational use of tPA in acute stroke

10 November 2022

230

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

Local low dose intra-arterial thrombolytic therapy: the risk of stroke or major haemorrhage

10 November 2022

232

1 reference

https://api.crossref.org/works/10.1016/0033-0620(92)90020-Z

10 November 2022

Identifiers

1 reference

15 August 2017

1 reference